A significant difference can be observed between hospice and nonhospice philosophy. Nonhospice units direct its effort to cure and sustain patient's life using disease-modifying therapeutic procedures, while hospice units focus on patient's quality of life. However, despite the differences between the 2 basic philosophies in question, both approaches share 1 aspect in common: the correct diagnosis of the patient. In any case above, laboratory analysis is a valuable tool. This work aims to compare the laboratory utilization between nonhospice cancer and hospice cancer units. Laboratory requests from patients within a 1-year period were evaluated and the hospice laboratory profile was presented. We demonstrated that nonhospice unit had a major volume of requested laboratory test than hospice unit, but for inpatients this difference was not so dramatic.
Showstack JA, Schroeder SA, Matsumato MFChanges in use of medical technologies, 1972-1977. N Engl J Med. 1982;211:1336-1339.
2.
Danzon PM, Manning WG Jr, Marquis MSFactors affecting laboratory test use and prices. Health Care Financ Rev. 1984;5:23-32.
3.
van Walraven C., Naylor D.Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA . 1998;280:550-558.
4.
Solomon DH, Hashimoto H., Daltroy L., Liang MHTechniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA. 1998;280: 2020-2027.
5.
Perraro F., Rossi P., Liva C., et al. Inappropriate emergency test ordering in a general hospital: preliminary reports. Qual Assur Health Care. 1992;4:77-81.
6.
Bareford D., Hayling A.Inappropriate use of laboratory services: long term combined approach to modify request patterns. BMJ. 1990;301:1305-1307.
Mozes B., Lubin D., Modan B., Bem-Bassat I., Gitel SN, Halkin H.Evaluation of an intervention aimed at reducing appropriate use of preoperative blood coagulation tests. Arch Intern Med. 1989;149:1836-1838.
9.
Rang M.The Ulysses syndrome. Can Med Assoc J. 1972 ;106:122-123.
10.
Moloney TW, Rogers DEMedical technology: a different view of the contentious debate over costs . N Engl J Med. 1979;301:1413-1419.
11.
Fineberg HV , Pearlman LALow-cost medical practices. Annu Rev Public Health. 1982;3:225-248.
12.
Lewis S., Foreman J.Low-cost diagnostic technologies and clinical outcomes: the impact of inappropriate utilization. Int J Technol Assess Health Care. 1997;13:501-511.
13.
Lester E.A new strategy for out-of-hours laboratory investigations. Ann Clin Biochem. 1986;23:497-500.
14.
Davis MP, Walsh D., Nelson K., Konrad D., LeGrand SBThe business of palliative medicine: management metrics for an acute-care inpatient unit. Am J Hosp Palliat Care. 2001 ;18:26-29.
15.
Davis MO, Walsh D., Nelson KA, Konrad D., LeGrand SB, Rybicki L.The business of palliative medicine-part 2: the economics of acute inpatient palliative medicine. Am J Palliat Care. 2002 ;19:89-95.
16.
Davis MP, Walsh D., LeGrand SB, Langman RL, Harrison B., Rybicki L.The financial benefits of acute inpatient palliative medicine: an inter-institutional comparative analysis by all patient refined-diagnosis related group and case mix index. J Support Oncol. 2005;3:313-316.
17.
Körner E.First Report to the Secretary of State of the Steering Group on Health Services Information. London: HMSO; 1984:109.
18.
Smith SA, Veglia JMHospital utilization of laboratory tests, procedures, and special therapies . Am J Hosp Palliat Med. 1986;3:33-36.
19.
Lewin SN, Buttin BM, Powel MA, et al. Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol. 2005;99:261-266.
20.
Wang TJ, Mort EA, Nordberg P., et al. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med. 2002;162: 1885-1890.
21.
Maltoni M., Amadori D.Prognosis in advanced cancer. Hematol Oncol Clin North Am . 2002;16:715-729.
22.
Gripp S., Moeller S., Bölke E., et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25:3313-3320.
23.
Suh SY, Ahn HYLactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer. 2007;43:1051-1059.
24.
Lau F., Cloutier-Fisher D., Kuziemsky C., et al. A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care. 2007 ;23:93-112.
